Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.

Abdelal, Randa; Raja Banerjee, A; Carlberg-Racich, Suzanne; Darwaza, Neyla; Ito, Diane; Shoaff, Jessica; Epstein, Josh

Abdelal, Randa; Raja Banerjee, A; Carlberg-Racich, Suzanne; Darwaza, Neyla; Ito, Diane; Shoaff, Jessica; Epstein, Josh.

Affiliation

Abdelal R; Hikma Pharmaceuticals USA Inc., 200 Connell Drive, 4th Floor, Berkeley Heights, NJ, 07922, USA. rabdelal@hikma.com.
Raja Banerjee A; Hikma Specialty USA Inc., Berkeley Heights, NJ, USA.
Carlberg-Racich S; DePaul University, Chicago, IL, USA.
Darwaza N; Hikma Pharmaceuticals LLC, Amman, Jordan.
Ito D; Stratevi, LLC, Santa Monica, CA, USA.
Shoaff J; Stratevi, LLC, Boston, MA, USA.
Epstein J; Stratevi, LLC, Santa Monica, CA, USA.

Harm Reduct J ; 19(1): 49, 2022 05 20.

Article in En | MEDLINE | ID: mdl-35596213

Subject(s)

COVID-19; Drug Overdose; Opiate Overdose; Substance Withdrawal Syndrome; Adult; Analgesics, Opioid/therapeutic use; Cross-Sectional Studies; Drug Overdose/drug therapy; Drug Overdose/epidemiology; Female; Humans; Male; Naloxone/therapeutic use; Narcotic Antagonists/therapeutic use; Nasal Sprays; Pandemics; Substance Withdrawal Syndrome/drug therapy

Key words

Bystander; COVID-19; Dosing; Fentanyl; Layperson; Multiple naloxone administrations; Naloxone; Narcan; Opioid overdose; Synthetic opioid

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Substance Withdrawal Syndrome / Drug Overdose / Opiate Overdose / COVID-19 Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Harm Reduct J Year: 2022 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google